EPCAM and breast cancer: This study presents a novel finding that ANXA2 is an interacting partner of EpCAM in the EpCAM+ ERα+ breast cancer cells, and co‐localizes with EpCAM at the plasma membrane of EpCAM+ ERα+ breast cancer cells.